Genetic Dissection of Systemic Lupus Erythematosu Pathogenesis: Sle2 on Murine Chromosome 4 Leads to B Cell Hyperactivity

Journal of Immunology

Volumn 159, Issue 1, 1997, Pages 454-465

  Mohan, Chandra ^a   Morel, Laurence ^a   Yang, Ping ^a   Wakeland, Edward K ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; B LYMPHOCYTE; C57BL MOUSE; CHROMOSOME MAP; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; B-LYMPHOCYTES; CHROMOSOME MAPPING; GENETIC PREDISPOSITION TO DISEASE; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL;

EID: 0031179651     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Mohan, C., and S. K. Datta. 1995. Lupus: key pathogenic mechanisms and contributing factors. Clin. Immunol. Immunopathol. 77:209.
2. Theofilopoulos, A. N. 1995. The basis of autoimmunity. I. Mechanisms of aberrant self-recognition. Immunol. Today 16:90.
3. Vyse, T. J., and J. A. Todd. 1996. Genetic analysis of autoimmune disease. Cell 85:311.
4. Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer, and E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1:219.
5. Rudofsky, U. H., B. D. Evans, S. L. Balaban, V. D. Mottironi, and A. E. Gabrielsen. 1993. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand Black and New Zealand White mice: origins and initial characteization. Lab. Invest. 68:419.
6. Drake, C. G., S. J. Rozzo, T. J. Vyse, E. Palmer, and B. L. Kotzin. 1995. Genetic contributions to lupus-like disease in (NZB × NZW)F1 mice. Immunol. Rev. 144:51.
7. Theofilopoulos, A. N. 1995. The basis of autoimmunity. II. Genetic predisposition. Immunol. Today 16:150.
8. Morel, L., Y. Yu, K. R. Blenman, R. A. Caldwell, and E. K. Wakeland. 1996. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm. Genome 7:335.
9. Mohan, C., S. Adams, V. Stanik, and S. K. Datta. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177:1367.
10. Mohan, C., Y. Shi, J. D. Laman, and S. K. Datta. 1995. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154:1470.
11. Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271.
12. Ando, D. G., F. M. Ebling, and B. H. Hahn. 1986. Detection of native and denatured DNA antibody forming cells by the enzyme-linked immunospot assay. Arthritis Rheum. 29:1139.
13. hl splenic B cells arc un immature developmental intermediate in the production of long-lived marrow-derived B cells. J. Immunol. 151:4431.
14. Waldschmidt, T. J. 1996. B cell subpopulations and microenvironments. In Cytokine Regulation of Humoral Immunity: Basic and Clinical Aspects. C. M. Snapper, ed. John Wiley & Sons Ltd., New York, pp. 73-98.
15. Wells, S. M., A. M. Stall, A. B. Kantor, and L. A. Herzenberg. 1995. Development of B cell subsets. In Immunoglobulin Genes. T. Honjo and F. W. Alt, eds. Academic Press Ltd., Orlando, pp. 83-101.
16. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythemutosus. Adv. Immunol. 37:269.
17. East, J. 1970. Immunopathology and Neoplasms in New Zealand Black (NZB) and SJL/J mice. Prog. Exp. Tumor Res. 13:84.
18. Klinman, D. M., and A. D. Steinberg. 1995. Inquiry into murine and human lupus. Immunol. Rev. 144:157.
19. Klinman, D. M., and A. D. Steinberg. 1987. Systemic autoimmune disease arises from polyclonal B cell activation. J. Exp. Med. 165:1755.
20. Playfair, J. H. L. 1968. Strain differences in the immune responses of mice. I. The neonatal response to sheep red cells. Immunology 15:35.
21. Staples, P. J., and N. Talal. 1969. Relative inability to induce tolerance in adult NZB and NZB/NZW F1 mice. J. Exp. Med. 129:123.
22. Cohen, P. L., and M. Ziff. 1977. Abnormal polyclonal B cell activation in NZB/NZW F1 mice. J. Immunol. 119:1534.
23. Moutsopoulos, H. M., M. Bochm Truitt, S. S. Kassan, and T. M. Chused. 1977. Demonstration of activation of B lymphocytes in New Zealand Black mice at birth by an immunoradiometric assay for murine IgM. J. Immunol. 119:1639.
24. Theofilopoulos, A. N., D. L. Shawler, R. A. Eisenberg, and F. J. Dixon. 1980. Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice. J. Exp. Med. 151:446.
25. Jyonouchi, H., P. W. Kincade, R. A. Good, and M. E. Gershwin. 1983. B lymphocyte lineage cells in newborn and very young NZB mice: evidence for regulatory disorders affecting B cell formation. J. Immunol. 131:2219.
26. Perkins, D. L., R. M. Glaser, C. A. Mahon, J. Michaelson, and A. Marshak Rothstein. 1990. Evidence for an intrinsic B cell defect in lpr/lpr mice apparent in neonatal chimeras. J. Immunol. 145:549.
27. Sobel, E. S., T. Katagiri, K. Katagiri, S. C. Morris, P. L. Cohen, and R. A. Eisenberg. 1991. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J. Exp. Med. 173:1441.
28. Nemazee, D., C. Guiet, K. Buerki, and A. Marshak Rothstein. 1991. B lymphocytes from the autoimmune-prone mouse strain MLR/lpr manifest an intrinsic defect in tetraparental MRL/lpr in equilibrium DBA/2 chimeras. J. Immunol. 147:2536.
29. Reininger, L., T. Radaszkiewicz, M. Kosco, F. Melchers, and A. G. Rolink. 1992. Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZB × NZW)F1 pre-B cells. J. Exp. Med. 176:1343.
30. Reininger, L., T. H. Winkler, C. P. Kalberer, M. Jourdan,. F. Melchers, and A. G. Rolink. 1996. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB × NZW)F1 mice. J. Exp. Med. 184:853.
31. Budman, D. R., E. B. Merchant, A. D. Steinberg, B. Doft, M. E. Gershwin, E. Lizzio, and J. P. Reeves. 1977. Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Arthritis Rheum. 20:829.
32. Fauci, A. S., and H. M. Moutsopoulos. 1981. Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjogren's syndrome. Arthritis Rheum. 24:577.
33. Sakane, T., N. Suzuki, S. Takada, Y. Ueda, Y. Murakawa, T. Tsuchida, Y. Yamauchi, and T. Kishimoto. 1988. B cell hyperactivity and its relation to distinct clinical features and the degree of disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 31:80.
34. Klinman, D. M., A. Shirai, Y. Ishigatsubo, J. Conover, and A. D. Steinberg. 1991. Quantisation of IgM- and IgG-secreting B cells in the peripheral blood of patients with systemic lupus erythematosus. Arthritis Rheum. 34:1404.
35. Stollar, B.D. 1971. Reactions of systemic lupus erythematosus sera with histone fractions and histone-DNA complexes. Arthritis Rheum. 14:485.
36. Burlingame, R. W., R. L. Rubin, R. S. Balderas, and A. N. Theofilopoulos. 1993. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J. Clin. Invest. 91:1687.
37. Burlingame, R. W., M. L. Boey, G. Starkebaum, and R. L. Rubin. 1994. The central role of chromatin in autoimmune responses to hi stones and DNA in systemic lupus erythematosus. J. Clin. Invest. 94:184.
38. Desai-Mehta, A., C. Mao, S. Rajagopalan, T. Robinson, and S. K. Datta. 1995. Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J. Clin. Invest. 95:531.
39. Milich, D., and E. M. Gershwin. 1980. The pathogenesis of autoimmunity in New Zealand mice. Semin. Arthritis Rheum. 10:111.
40. Hayakawa, K., R. R. Hardy, D. R. Parks, and L. A. Herzenberg. 1983. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med. 157:202.
41. + B cells. Clin. Immunol. Immunopathol. 56:135.
42. Kasaian, M. T., and P. Casali. 1995. B-1 cellular origin and VH segment structure of IgG, IgA, and IgM anti-DNA autoantibodies in patients with systemic lupus erythematosus. Ann. NY Acad. Sci. 764:410.
43. Murakami, M., H. Yoshioka, T. Shirai, T. Tsubata, and T. Honjo. 1995. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int. Immunol. 7:877.
44. Herzenberg, L. A., and A. B. Kantor. 1992. Layered evolution in the immune system: a model for the ontogeny and development of multiple lymphocyte lineages. Ann. NY Acad. Sci. 651:1.
45. Rabin, E., Y. Z. Cong, and H. H. Wortis. 1992. Loss of CD23 is a consequence of B-cell activation: implications for the analysis of B-cell lineages. Ann. NY Acad. Sci. 651:130.
46. Wortis, H. H., M. Teutsch, M. Higer, J. Zheng, and D. C. Parker. 1995. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc. Natl. Acad. Sci. USA 92:3348.
47. Liou, L. B., A. Colosia, R. B. Corley, S. H. Clarke, and D. W. Scott. 1995. Differential susceptibility to tolerance induction in vitro of splenic B cells from several transgenic mouse lines: role of B1 cells. J. Immunol. 154:6262.
48. - B cells of patients with systemic lupus erythematosus. J. Clin. Invest. 85:238.
49. Reap, E. A., E. S. Sobel, P. L. Cohen, and R. A. Eisenberg. 1993. Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice. J. Exp. Med. 177:69.
50. Murakami, M., T. Tsubata, M. Okamoto, A. Shimizu, S. Kumagai, H. Imura, and T. Honjo. 1992. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 357:77.
51. Engel, P., L. J. Zhou, D. C. Ord, S. Sata, B. Koller, and T. F. Tedder. 1996. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39.
52. Ahearn, J. M., M. B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251.
53. O'Keefe, T. L., G. T. Williams, S. L. Davies, and M. S. Neuberger. 1996. Hyperresponsive B cells in CD22-deficient mice. Science 274:798.
54. Sato, S., N. Ono, D. A. Steeber, D. S. Pisetsky, and T. F. Tedder. 1996. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 157:4371.
55. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3:549.
56. Khan, W. N., F. W. Alt, R. M. Gerstein, B. A. Malynn, I. Lanson, G. Rathbun, L. Davidson, S. Muller, A. B. Kantor, L. A. Herzenberg, F. S. Rosen, and P. Sideras. 1995. Defective B cell development and function in Btk-deticient mice. Immunity 3:283.
57. Zhang, R., F. W. Alt, L. Davidson, S. H. Orkin, and W. Swat. 1995. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374:470.
58. Tarakhovsky, A., M. Turner, S. Schaal, P. J. Mee, L. P. Duddy, K. Rajewsky, and V. L. Tybulewicz. 1995. Defective antigen receptor-mediated proliferation of B and T cells in the absence of vav. Nature 374:467.
59. Cyster, J. G., and C. C. Goodnow. 1995. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2:13.
60. Zhang, L., A. Eddy, Y. T. Teng, M. Fritzler, M. Kluppel, F. Melet, and A. Bernstein. 1995. An immunological renal disease in transgenic mice that over-express Fli-1, a member of the ets family of transcription factor genes. Mol. Cell. Biol. 15:6961.
61. Klinmun, D. M. 1990. Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease. J. Clin. Invest. 86:1249.
62. Cohen, P., M. Ziff, and E. S. Vitetta. 1978. Characterization of a B cell defect in the NZB mouse manifested by an increased ratio of surfuce IgM to IgD. J. Immunol. 121:973.
63. Theofilopoulos, A. N., R. A. Eisenberg, M. Bourdon, J. S. Crowell, Jr., and F. J. Dixon. 1979. Distribution of lymphocytes identified by surfuce markers in murine strains with systemic lupus erythematosus-like syndromes. J. Exp. Med. 149:516.
64. Pike, B. L., J. E. Layton, N. R. Rose, and G. J. Nossal. 1981. Surface immunoglobulin isotype, activation, and tolerance susceptibility of B lymphocytes of New Zealand Black mice. Cell. Immunol. 63:385.
65. Carsetti, R., G. Kohler, and M. C. Lamers. 1995. Transitional B cells are the target of negative selection in the B cell compartment. J. Exp. Med. 181:2129.
66. Li, Y. S., K. Hayakawa, and R. R. Hardy. 1993. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J. Exp. Med. 178:951.
67. Feeney, A. J. 1990. Lack of N regions in fetal and neonatal mouse immunoglobulin V-D-J junctionul sequences. J. Exp. Med. 172:1377.
68. Kantor, A. B., A. M. Stall, S. Adams, and L. A. Herzenberg. 1992. Differential development of progenitor activity for three B-cell lineages. Proc. Natl. Acad. Sci. USA 89:3320.
69. Huyakuwa, K., C. E. Carmack, R. Hymun, and R. R. Hardy. 1990. Nuturul autoantibodies to thymocytes: origin, VH genes, fine specificities, and the role of Thy-1 glycoprotein. J. Exp. Med. 172:869.
70. Lum, K. P., and A. M. Stall. 1994. Major histocompatibility complex class II expression distinguishes two distinct B cell developmental pathways during ontogeny. J. Exp. Med. 180:507.
71. Hayakawa, K., D. Tarlinton, and R. H. Hurdy. 1994. Absence of MHC class II expression distinguishes fetal from adult B lymphopoiesis in mice. J. Immunol. 152:4801.